Switch to PDF version
Audio Broadcast Version
Compound Berberine Tannic Acid Protein Capsules
Release time:
2024-10-24
Font scaling:
Drug name
Xie Li Lang
Generic Name: Compound Berberine Hydrochloride and Tannalbin Capsules
English Name: Compound Berberine Hydrochloride and Tannalbin Capsules
Ingredients
This product is a compound formulation. Each capsule contains: 120 mg of berberine hydrochloride, 300 mg of tannic protein, 2 mg of chlorpheniramine maleate, 5 mg of thiamine nitrate, 30 mg of ethacridine lactate, and 43 mg of aluminum silicate.
Characteristics
This product is a capsule containing a pale yellow or yellow powder or granules.
Indications
For dysentery, acute and chronic enteritis, and other conditions.
Specifications
0.5 grams.
Dosage and Administration
Oral administration. Adults: 1-2 capsules once or twice daily; children aged 8-15: 1/2 capsule each time, or as directed by a physician.
Adverse reaction
Not yet clear.
Taboo
Do not use if you are allergic to this product.
Precautions
1. Do not take if the characteristics have changed.
2. If you are taking other medications, please consult your doctor or pharmacist before using this product. Pregnant women and breastfeeding women
Not yet clear.
Pediatric Medication
Not yet clear.
Medication for the elderly
Not yet clear.
Drug interactions
Not yet clear.
Drug overdose
Not yet clear.
Pharmacological effects
Berberine hydrochloride exhibits antibacterial activity against Shigella, Vibrio cholerae, Staphylococcus aureus, Salmonella, and Proteus.
Tannic acid protein is formed by the combination of tannic acid and albumin. In the intestine, under the action of pancreatic juice, it gradually transforms into tannic acid alkali, which has astringent properties. Tannic acid can also cause proteins to coagulate, thereby forming a protective film on the intestinal mucosa.
Aluminum silicate has an adsorptive effect and can also remove harmful substances, excess water, and mucus from the gastrointestinal tract, while also providing a protective effect on the mucous membranes.
Ethacridine lactate is a bactericide that exhibits antibacterial activity against many Gram-positive bacteria and effectively inhibits the proliferation of intestinal bacteria.
Tannic acid protein is formed by the combination of tannic acid and albumin. In the intestine, under the action of pancreatic juice, it gradually transforms into tannic acid alkali, which has astringent properties. Tannic acid can also cause proteins to coagulate, thereby forming a protective film on the intestinal mucosa.
Aluminum silicate has an adsorptive effect and can also remove harmful substances, excess water, and mucus from the gastrointestinal tract, while also providing a protective effect on the mucous membranes.
Ethacridine lactate is a bactericide that exhibits antibacterial activity against many Gram-positive bacteria and effectively inhibits the proliferation of intestinal bacteria.
Pharmacokinetics
Not yet clear.
Storage
Shade from light and store in a sealed container.
Packaging
Aluminum-plastic packaging, 4 tablets/box, 6 tablets/box, 10 tablets/box.
Validity period
24 months.
Implementation standard
The national pharmaceutical standard for chemical drugs, the local standard, has been elevated to the national standard, Volume XII, WS-10001-(HD-1111)-2002.
Approval Number
National Drug Approval Number H52020606